Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (1028) Besivance (besifloxacin ophthalmic suspension), Bausch & Lomb,
...by susceptible isolates of the following bacteria: • Corynebacterium pseudodiphtheriticum • Corynebacterium striatum Haemophilus influenzae • Moraxella lacunata • Staphylococcus aureus • Staphylococcus epidermidis • Staphylococcus hominis • Staphylococcus lugdunensis • Streptococcus mitis group • Streptococcus oralis • Streptococcus pneumoniae • Streptococcus salivarius Besivance ...
View Page

2.  Study Posting (96) Trial #160056, Psoriasis and Psoriatic Disorders, New York, NY
...Posting (96) Trial #160056, Psoriasis and Psoriatic Disorders, New York, NY Trial Information Eradication of Staphylococcus Aureus from Skin Lesions Through the Use of a Newly Developed Lytic Enzyme Called ClyS ...
...are produced because of abnormal skin conditions. There is a specific type of bacteria called Staphylococcus aureus that is often found on the skin of patients with psoriasis. We are interested ...
View Page

3.  Study Posting (77) Trial #144411, Vaccines, New York, NY
...Trial #144411, Vaccines, New York, NY Trial Information Clinical trial to test a study drug Staphylococcus aureus Vaccine (V710) in Adult Patients Scheduled for Cardiothoracic Surgery. The purpose of this experimental ...
...York support@centerwatch.com Arlene.travis@mssm.edu Clinical trial to test a study drug Staphylococcus aureus Vaccine (V710) in Adult Patients Scheduled for Cardiothoracic Surgery. Vaccines New York, NY 144411 ...
View Page

4.  Newly Approved Drug Therapies (946) Altabax (retapamulin), GlaxoSmithKline,
...Name: Altabax (retapamulin) Company: GlaxoSmithKline Approval Status: Approved April 2007 Treatment Area: impetigo due to Staphylococcus aureus or Streptococcus pyogenes General Information Altabax is a bacterial protein synthesis inhibitor belonging to ...
...2% total body surface area in pediatric patients aged 9 months or older) due to Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes. Altabax is supplied as a gel in ...
View Page

5.  CenterWatch: New Medical Therapies in Disease Category (354), Staphylococcal Infections
...trial of Veronate , their investigational antibody-based therapy for the prevention of hospitalization associated with Staphylococcus aureus infections. This multi-center, placebo controlled, double-blind study enrolled 2017 infants across 95 ...
...a phase I trial of their S. aureus Type 336 vaccine , for the prevention of Staphylococcus aureus infections. The vaccine was seen to be safe and well tolerated, and dose-related ...
View Page

6.  Study Posting (2040) Trial #95990, Pneumonia, Fort Lauderdale, FL
...for Hospital Acquired Pneumonia with an emphasis on patients with infections due to methicillin-resistant Staphylococcus aureus. Several Study Inclusion Criteria Include: • Pneumonia acquired after 48 hours of continuous stay in ...
View Page

7.  Study Posting (2326) Trial #156939, Wounds, West Palm Beach, FL
...Linezolid in the Treatment of Secondarily-Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus aureus Do you have a scrape, impetigo, stitches, cut, scratch, or impetigo? Call today to ...
...Linezolid in the Treatment of Secondarily-Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus aureus Wounds West Palm Beach, FL 156939 Clinical Trial Participation If you would like to ...
View Page

8.  Newly Approved Drug Therapies (1061) Tygacil (tigecycline), Wyeth,
...Complicated skin and skin structure infections caused by Escherichia coli, Enterococcus faecalis (vancomycin-susceptible isolates), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus agalactiae, Streptococcus anginosus grp. (includes S. anginosus, S ...
...Citrobacter freundii, Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Enterococcus faecalis (vancomycin-susceptible isolates), Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus anginosus grp. (includes S. anginosus, S. intermedius , and ...
View Page

9.  Newly Approved Drug Therapies (107) Cipro (ciprofloxacin HCl), Bayer,
...Cipro has been approved as treatment for acute, uncomplicated cystitis, caused by E.coli or Staphylococcus saprophyticus. Cystitis is one of the most common urinary tract infections (UTI) in females. Cipro ...
View Page

10.  CenterWatch: List of Newly Approved Drug Thearapies
...March 2007 Dermatology/Plastic Surgery Altabax (retapamulin) ; GlaxoSmithKline; For the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes, Approved April 2007 Extina (ketoconazole) ; Stiefel; For the treatment of seborrheic ...
...March 2007 Immunology/Infectious Diseases Altabax (retapamulin) ; GlaxoSmithKline; For the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes, Approved April 2007 AzaSite (azithromycin) ; InSite Vision; For the treatment of ...
View Page

11.  Newly Approved Drug Therapies (948) AzaSite (azithromycin), InSite Vision,
...conjunctivitis caused by susceptible isolates of the following microorganisms: CDC coryneform group G, Haemophilus influenzae, Staphylococcus aureus, Streptococcus mitis group, Streptococcus pneumoniae AzaSite is supplied as a sterile aqueous ophthalmic formulation ...
...microorganisms, both in vitro and clinically in conjunctival infections: CDC coryneform group G, Haemophilus influenzae, Staphylococcus aureus, Streptococcus mitis group, Streptococcus pneumoniae Literature References Kuehne JJ, Yu AL, Holland GN, Ramaswamy ...
View Page

12.  Newly Approved Drug Therapies (117) Zosyn (sterile piperacillin sodium/tazobactam sodium), Wyeth,
...to severe nosocomial (hospital-acquired) pneumonia caused by piperacillin-resistant beta-lactamase-producing strains of Staphylococcus aureus. Nosocomial pneumonia is a disease that has proven increasingly resistant to many available antibiotics ...
View Page

13.  Newly Approved Drug Therapies (94) Bactroban Nasal 2% (mupirocin calcium ointment), SmithKline Beecham,
...as an intranasally administered topical agent for the eradication of nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA). This treatment has been approved for adult subjects and health care workers as ...
View Page

14.  CenterWatch: Dermatology/Plastic Surgery Approved Drug Therapies
...2009 Drugs Approved in 2007 Altabax (retapamulin) ; GlaxoSmithKline; For the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes, Approved April 2007 Extina (ketoconazole) ; Stiefel; For the treatment of seborrheic ...
View Page

15.  CenterWatch: New Medical Therapies in Disease Category (177), Skin Infections/Disorders
...of 93.6% for all pathogens. The ceftaroline clinical cure rate was 93.1% in Staphylococcus aureus infections in the microbiologically evaluable population and 93.3% for MRSA infections. Treatment was ...
...the subjects treated with vancomycin. The clinical cure rates for the subjects with methicillin-resistant Staphylococcus aureus (MRSA) infections were 94.7% for the TD-1792 arm and 91.9% in ...
View Page

16.  CenterWatch: Clinical Trials in Category (205) Wounds
...Linezolid in the Treatment of Secondarily-Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus aureus Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson Medical Information LLC. Designed by ...
View Page

17.  Newly Approved Drug Therapies (1055) Vibativ (telavancin), Theravance,
...and skin structure infections (cSSSI) caused by susceptible isolates of the following Gram-positive microorganisms: Staphylococcus aureus (including methicillin-susceptible and -resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus anginosus group (includes ...
View Page

18.  CenterWatch: New Medical Therapies in Disease Category (465), Bacterial Infections
...of 93.6% for all pathogens. The ceftaroline clinical cure rate was 93.1% in Staphylococcus aureus infections in the microbiologically evaluable population and 93.3% for MRSA infections. Treatment was ...
...the subjects treated with vancomycin. The clinical cure rates for the subjects with methicillin-resistant Staphylococcus aureus (MRSA) infections were 94.7% for the TD-1792 arm and 91.9% in ...
View Page

19.  Newly Approved Drug Therapies (585) Synercid I.V., Rhone Poulenc Rorer,
...is presently underway. Another disease would be complicated skin and skin structure infections caused by Staphylococcus aureus (methicillin susceptible) or Streptococcus pyogenes. Clinical Results Results are available from four non-comparative ...
...substituted for the specified comparator if the causative pathogen was suspected or confirmed methicillin-resistant staphylococcus or if the patient was allergic to penicillins, cephalosporins or carbapenems. Study JRV 304 enrolled ...
View Page

20.  Newly Approved Drug Therapies (701) Finevin, Berlex Laboratories,
...effective in treating mild to moderate acne. FINEVIN demonstrated antimicrobial activity against Propionibacterium acnes and Staphylococcus epidermis, normalized the follicular hyperkeratosis associated with acne, and produced anti-inflammatory effects. In the ...
View Page